Entonox as an analgesic agent during panretinal photocoagulation.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 12234887.
- Also identified by PMC identifier 1771318.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Panretinal photocoagulation (PRP) reduces the risk of visual loss in proliferative diabetic retinopathy but some patients cannot tolerate PRP because of pain. Inhaled Entonox was evaluated as an analgesic during PRP. A randomised, crossover, double masked pilot study was performed. Patients inhaled either air or Entonox and half the PRP was applied. The treatment was completed with the alternate inhaled gas. Patients graded pain experienced during both stages of the treatment using a visual analogue scale. Pain scores were compared using a paired t test. 20 patients participated. Mean pain scores from the Entonox and air treatments were 2.94 (SD 2.73) versus 3.73 (SD 3.20) respectively (p<0.03). Entonox can be used as a safe and effective analgesic agent during PRP treatment.
Medical subject headings
- Analgesics
- Anesthetics, Combined
- Diabetic Retinopathy
- Light Coagulation
- Nitrous Oxide
- Oxygen